ZEO ScientifiX (ZEOX) Action Cours

ZEO ScientifiX Inc, with ticker ZEOX and ISIN US68621D2062, is a biotechnology company headquartered in Davie, Florida, operating within the Health Care sector. The company has 20 employees and completed its initial public offering (IPO) on November 8, 2013. Its website is https://organicell.com. ZEO ScientifiX Inc focuses on the development of biological therapeutics for degenerative diseases. The company's products are administered through medical professionals and clinics within the healthcare industry. The firm has received FDA approvals, including Investigation New Drug (IND) and emergency IND (eIND) clearances, along with necessary Institutional Review Board (IRB) approvals for its therapeutic applications. The company's primary product, Zofin (Organicell Flow), is described as an acellular biologic therapeutic derived from perinatal sources. It is manufactured to preserve naturally occurring microRNAs without the addition of other substances or diluents. The product is noted to contain over 300 growth factors, cytokines, chemokines, and 102 unique microRNAs, alongside other exosomes sourced from perinatal tissues. The company operates as a clinical-stage biopharmaceutical entity, emphasizing regenerative medicine approaches. ZEO ScientifiX Inc is engaged in the development of innovative treatments aimed at addressing degenerative conditions through advanced biological therapies. The company's operations and product development are grounded in the use of perinatal-derived biological materials, focusing on therapeutic applications that leverage natural biological components. ZEO ScientifiX Inc maintains a presence in the biotechnology industry with a focus on regenerative medicine and the delivery of novel therapeutic solutions for degenerative diseases.